Form 8-K - Current report:
SEC Accession No. 0001293971-21-000076
Filing Date
2021-10-08
Accepted
2021-10-08 17:03:46
Documents
13
Period of Report
2021-10-08
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K blue-20211008.htm   iXBRL 8-K 34769
2 EX-99.1 exhibit99120211008.htm EX-99.1 21456
  Complete submission text file 0001293971-21-000076.txt   200055

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT blue-20211008.xsd EX-101.SCH 1923
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT blue-20211008_lab.xml EX-101.LAB 24270
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT blue-20211008_pre.xml EX-101.PRE 12652
6 EXTRACTED XBRL INSTANCE DOCUMENT blue-20211008_htm.xml XML 11260
Mailing Address 60 BINNEY STREET CAMBRIDGE MA 02142
Business Address 60 BINNEY STREET CAMBRIDGE MA 02142 339-499-9300
bluebird bio, Inc. (Filer) CIK: 0001293971 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35966 | Film No.: 211315944
SIC: 2836 Biological Products, (No Diagnostic Substances)